Impact of sildenafil on echocardiographic indices of myocardial performance after the fontan operation

Pediatric Cardiology

Volumn 33, Issue 5, 2012, Pages 689-696

  Goldberg, David J ^a,b   French, Benjamin ^b   Szwast, Anita L ^a,b   McBride, Michael G ^a   Marino, Bradley S ^c   Mirarchi, Nicole ^a   Hanna, Brian D ^a,b   Wernovsky, Gil ^a,b   Paridon, Stephen M ^a,b   Rychik, Jack ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Fontan procedure; Physiology; Sildenafil; Trials

Indexed keywords

PLACEBO; SILDENAFIL;

ADOLESCENT; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FONTAN PROCEDURE; FUNCTIONAL STATUS; HEART FUNCTION; HEART OUTPUT; HEART SINGLE VENTRICLE; HEART VENTRICLE FAILURE; HUMAN; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; LINEAR MODELS; MALE; OXYGEN CONSUMPTION; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PLACEBOS; PURINES; SULFONES; TREATMENT OUTCOME;

EID: 84863986857     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0196-9     Document Type: Article

References (26)

1. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE et al (2008) Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 52:85-98
2. Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N (2008) Effects of 50-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J Card Fail 14:189-197
3. Caldas MC, Meira ZA, Barbosa MM (2008) Evaluation of 107 patients with sickle cell anemia through tissue Doppler and myocardial performance index. J Am Soc Echocardiogr 21:1163-1167
4. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK et al (2007) Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 115:658-676
5. Cheung EW, Lam WW, Cheung SC, Cheung YF (2008) Functional implications of the right ventricular myocardial performance index in patients after surgical repair of tetralogy of Fallot. Heart Vessels 23:112-117
6. Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Muller J, Derrick G et al (2010) Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 31(24):3073-3083
7. Fontan F, Baudet E (1971) Surgical repair of tricuspid atresia. Thorax 26:240-248
8. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD et al (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185-1193
9. Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) PDE5-inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of a 1-year prospective, randomized, placebo-controlled study. Circ HeartFail 4(1):8-17
10. Jenkins PC, Chinnock RE, Jenkins KJ, Mahle WT, Mulla N, Sharkey AM et al (2008) Decreased exercise performance with age in children with hypoplastic left heart syndrome. J Pediatr 152:507-512
11. Kenward MG, Roger JH (2010) The use of baseline covariates in crossover studies. Biostatistics 11:1-17
12. Klimes K, Ovroutski S, Abdul-Khaliq H, Ewert P, Alexi- Meskishvili V, Kuehne T et al (2009) Exercise capacity reflects ventricular function in patients having the Fontan circulation. Cardiol Young 19(4):340-345
13. Kreutzer G, Galindez E, Bono H, De Palma C, Laura JP (1973) An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 66:613-621
14. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM et al (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413-1430
15. Morner S, Lindqvist P, Waldenstrom A, Kazzam E (2008) Right ventricular dysfunction in hypertrophic cardiomyopathy as evidenced by the myocardial performance index. Int J Cardiol 124:57-63
16. Nagayama T, Hsu S, Zhang M, Koitabashi N, Bedja D, Gabrielson KL et al (2009) Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload. J Am Coll Cardiol 53:207-215
17. Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A et al (2007) Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116:238-248
18. Patel N, Mills JF, Cheung MM (2009) Use of the myocardial performance index to assess right ventricular function in infants with pulmonary hypertension. Pediatr Cardiol 30:133-137
19. Pokreisz P, Vandenwijngaert S, Bito V, Van den Bergh A, Lenaerts I, Busch C et al (2009) Ventricular phosphodiesterase-5
20. Rychik J (2010) Forty years of the Fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 13:96-100
21. Sarkar H, Siddique MA, Haque KM, Ahmed CM, Mahmood M, Bhattacharjee B et al (2008) Evaluation of left ventricular global function using Dopplermyocardial performance index in patients with systemic hypertension. Mymensingh Med J 17(Suppl): S65-S71
22. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER et al (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11:214-222
23. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy.J Cardiol 26:357-366
24. Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P,Mitchell ME et al (2009) Fontan palliation in the modern era:factors impacting mortality and morbidity. Ann Thorac Surg 88:1291-1299
25. Zhang YQ, Sun K, Zhu SL, Wu LP, Chen GZ, Zhang ZF et al(2008) Doppler myocardial performance index in assessment of ventricular function in children with single ventricles. World J Pediatr 4:109-113
26. Zhang M, Takimoto E, Hsu S, Lee DI, Nagayama T, Danner T